Patient Discovery expands reach of its equitable care platform through trusted vendor program BOSTON, Mass., May 11, 2023 – Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered technology and real-world data to help…
Amyloidosis is a group of rare diseases characterized by insoluble, extracellular protein (amyloid) deposition in various organs leading to organ dysfunction and failure. A total of 36 amyloidogenic proteins have been identified; 17 of these may go on to cause…
The Effectiveness of an Advance Care Appointment Companion to Increase Completion of Advance Care Planning among Patients with Metastatic Breast Cancer 1Kadie M. Harry, PhD, 1Cathy E. Mitchell, BS, 1Loic Nijiakin, BS, 2Arabella Sykes, BSc, & 1Timothy J. Pluard, MD…
Feasibility of a Supportive Mobile Health App for Chimeric Antigen Receptor T-Cell Therapy Session: 902. Health Services Research—Lymphoid Malignancies: Poster II Hematology Disease Topics & Pathways: Technology and Procedures, Clinical Practice (e.g. Guidelines, Health Outcomes and Services, and Survivorship, Value;…
In December 2020, Patient Discovery and ARC presented to the American Society of Hematology the findings of a 70-patient study at the Amyloidosis Center of Boston University Medical Center (BUMC)